SK hynix Inc. SKHY
150.79 USD +3.08 (+2.09%)
At closeNov 3, 2026, 6:52 PM EST
153.53 +2.74 +1.82%
After hours · Nov 3, 6:52 PM ET
149.79 Day range 154.05
124.80 52-week range 199.87
- YTD
- -10.25%
- 1 year
- -10.25%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 260.64 +72.9% upside
Now 150.79
- Target (low)
- 164.00
- Target (mean)
- 260.64
- Target (high)
- 400.00
Ratings (0m) 15 14 buy · 1 hold · 0 sell
- Strong buy5
- Buy9
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 15
- 1 month ago 14
- 2 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 8.96 | 8.21 – 9.78 | 0.00 | 0.0% | 131.67T | +301.1% | 3 |
| Next quarter | 8.70 | 8.06 – 9.34 | 0.00 | 0.0% | 131.72T | +150.5% | 2 |
| Current year | 26.89 | 25.44 – 27.99 | 0.00 | 0.0% | 363.94T | +274.6% | 5 |
| Next year | 42.30 | 33.29 – 52.70 | 26.89 | +57.3% | 578.04T | +58.8% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 28, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| Oct 28, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Oct 28, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Oct 28, 2026 | Needham | Maintained | Buy | Buy |
| Oct 26, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Sep 10, 2026 | JP Morgan | Initiated | — | Overweight |
| Aug 24, 2026 | Needham | Maintained | Buy | Buy |
| Aug 4, 2026 | Wolfe Research | Initiated | — | Outperform |
| Aug 4, 2026 | RBC Capital | Initiated | — | Outperform |
| Aug 4, 2026 | Cantor Fitzgerald | Initiated | — | Overweight |
| Aug 4, 2026 | Rosenblatt | Initiated | — | Buy |
| Aug 4, 2026 | Needham | Initiated | — | Buy |
| Aug 4, 2026 | William Blair | Initiated | — | Outperform |
| Aug 4, 2026 | Stifel | Initiated | — | Buy |
| Jul 30, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 30, 2026 | UBS | Initiated | — | Buy |
| Jul 14, 2026 | Barclays | Initiated | — | Overweight |
